Home LiteratureArticle Details
PMID: 2190244 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Expression of the sulfonamide resistance gene from plasmid R46.

Plasmid ·Vol. 23 ·No. 1 ·1990-01-00 ·Pages 35-41

Guerineau F, Brooks L, Mullineaux P

Abstract

The expression of the sul I gene from plasmid R46, a wide host range plasmid of the IncN incompatibility group, was studied in Escherichia coli. Using a promoter test vector, a promoter was detected upstream of the sul I gene. From a nuclease protection experiment, the transcription was determined to start 360 bp upstream of the coding sequence. Two putative promoter -35 and -10 sequences were found upstream from the predicted transcription start. The presence of this promoter sequence in other R factors was discussed in relation with previous data showing that the sul I genes were transcribed from other promoters. The translation product of the sul I gene was detected in minicells. Its size indicates that the translation starts at the first ATG codon found in the open reading frame.

MeSH Terms
Base Sequence Cloning, Molecular Drug Resistance, Microbial/genetics Escherichia coli/genetics Exons Gene Expression Regulation, Bacterial Genes, Bacterial Molecular Sequence Data Promoter Regions, Genetic Protein Biosynthesis R Factors/genetics Sulfonamides/pharmacology Transcription, Genetic
Chemicals
Sulfonamides
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Guerineau F
John Innes Institute, AFRC Institute of Plant Science Research, Norwich, United Kingdom.
Brooks L
Mullineaux P
Article Info
Journal
Plasmid
Abbr.
Plasmid
ISSN
0147-619X
Published
1990-01-00
Pages
35-41
Language
English
Region
United States
NLM ID
7802221
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com